These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28641926)

  • 21. IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells.
    Rasouli J; Casella G; Ishikawa LLW; Thome R; Boehm A; Ertel A; Melo-Silva CR; Mari ER; Porazzi P; Zhang W; Xiao D; Sigal LJ; Fortina P; Zhang GX; Rostami A; Ciric B
    Front Immunol; 2021; 12():679498. PubMed ID: 34149716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
    Casella G; Rasouli J; Thome R; Descamps HC; Vattikonda A; Ishikawa L; Boehm A; Hwang D; Zhang W; Xiao D; Park J; Zhang GX; Alvarez JI; Rostami A; Ciric B
    Front Immunol; 2020; 11():576752. PubMed ID: 33193372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
    Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
    PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.
    Prado C; Gaiazzi M; González H; Ugalde V; Figueroa A; Osorio-Barrios FJ; López E; Lladser A; Rasini E; Marino F; Zaffaroni M; Cosentino M; Pacheco R
    Front Immunol; 2018; 9():571. PubMed ID: 29619030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity.
    Russi AE; Walker-Caulfield ME; Guo Y; Lucchinetti CF; Brown MA
    J Autoimmun; 2016 Sep; 73():100-10. PubMed ID: 27396526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia and Dendritic Cells as a Source of IL-6 in a Mouse Model of Multiple Sclerosis.
    Gogoleva VS; Nguyen QC; Drutskaya MS
    Biochemistry (Mosc); 2024 May; 89(5):904-911. PubMed ID: 38880650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease.
    Ridwan S; Bauer H; Frauenknecht K; von Pein H; Sommer CJ
    J Neural Transm (Vienna); 2012 Nov; 119(11):1389-406. PubMed ID: 22430742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
    Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
    Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.
    Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S
    Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human GM-CSF interaction with the alpha-chain of its receptor studied using surface plasmon resonance.
    Revoltella RP; Laricchia Robbio L; Vikinge T; Pardi E; Levantini E; Beffy P
    Biosens Bioelectron; 1999 Jun; 14(6):555-67. PubMed ID: 11459101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b
    Zhu J; Liu JQ; Liu Z; Wu L; Shi M; Zhang J; Davis JP; Bai XF
    Front Immunol; 2018; 9():873. PubMed ID: 29740452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
    Paré A; Mailhot B; Lévesque SA; Lacroix S
    Brain Behav Immun; 2017 May; 62():1-8. PubMed ID: 27432634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
    Robinson AP; Caldis MW; Harp CT; Goings GE; Miller SD
    J Autoimmun; 2013 Jun; 43():32-43. PubMed ID: 23514872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
    Xiao BG; Zhu WH; Lu CZ
    Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.